# AbbVie Inc. (ABBV) — Q3-2019 Earnings Results

**Report date:** 2019-11-01 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2019

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 2.77%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.33 | N/A | +0.80% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management is pleased with the EPS results and remains focused on their strategic initiatives. However, they did not provide any updates on revenue guidance.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite lack of revenue guidance.

> They highlighted ongoing confidence in their product pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's strong EPS performance suggests that the company is managing its costs effectively and maintaining profitability. The stock's 2.77% increase indicates positive investor sentiment following the earnings report. However, the lack of revenue guidance may lead to uncertainty about future growth prospects.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2019_